Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study-Reference-Cited by-同舟云学术

Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study

Published:2014-03 Issue:15 Volume:32 Page:1745-1753
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Chlibek Roman,Smetana Jan,Pauksens Karlis,Rombo Lars,Van den Hoek J. Anneke R.,Richardus Jan H.,Plassmann Georg,Schwarz Tino F.,Ledent Edouard,Heineman Thomas C.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference27 articles.

1. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster;Gershon;J Clin Virol,2010

2. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP);Harpaz;MMWR Recomm Rep,2008

3. Zoster vaccine: current status and future prospects;Oxman;Clin Infect Dis,2010

4. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction;Yawn;Mayo Clin Proc,2007

5. Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine;Weinberg;J Infect Dis,2009

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The inactivated herpes zoster vaccine HZ/su induces a varicella zoster virus specific cellular and humoral immune response in patients on dialysis;eBioMedicine;2024-10

2. Efficacy, reactogenicity, and safety of the adjuvanted recombinant zoster vaccine for the prevention of herpes zoster in Chinese adults ≥ 50 years: A randomized, placebo-controlled trial;Human Vaccines & Immunotherapeutics;2024-06-05

3. Protecting patients with SLE against herpes zoster: time for early proactive vaccine counselling;The Lancet Rheumatology;2024-06

4. Immunogenicity, reactogenicity, and safety of two-dose adjuvanted herpes zoster subunit vaccine in patients with systemic lupus erythematosus in South Korea: a single-centre, randomised, double-blind, placebo-controlled trial;The Lancet Rheumatology;2024-06

5. Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression;Vaccines;2024-05-11